- The 8 States Most Likely to Legalize Marijuana Next
- BlackBerry Is Finally Realizing Smartphones Aren't the Answer
- Express Scripts and AbbVie Drug-Pricing Deal Might Devastate Biotech Bull Market
- Dow 18,000: Why This Market Rally May Never Happen Again
- Gilead Sciences Is Not a Buy; It's Heading Lower on Price War: Jim Cramer
Switzerland, the U.K., the Netherlands and Spain all were on the wrong side of the gold trade.
The betting now puts the Republican race between two people: Giuliani and Romney.
Shares could hit $1,000 by late January. But what kind of long-term returns would it offer?
There's a constant shuffling of the top ranks as the mutual-fund giant tries to revive sales.
The half-billion in losses indicate the kind of pressure CEO Chuck Prince faces.
Makes you wonder what Merrill would pay for a really good CEO.
There's little correlation between a team's payroll and success in the World Series.
A legendary bear stops calling for a meltdown. Why? Credit Fed head Ben Bernanke.
A survey also shows the managers underweight financials, which could presage a rebound in those stocks.
Through September, Democratic presidential candidates outraised Republican rivals by nearly $2 million from financial firms.